Chinese herbal decoction for treating Qi-Yin deficiency type angina pectoris of coronary heart disease

Abstract

The invention discloses a Chinese herbal decoction for treating Qi-Yin deficiency type angina pectoris of coronary heart disease. The Chinese herbal decoction is prepared from the following traditional Chinese medicinal materials by weight: 10 parts of oriental lapis, 11 parts of chicken oil, 12 parts of cardamom, 12 parts of Fructus Choerospondiatis, 14 parts of evening primrose oil, 10 parts ofimmature bitter orange, 8 parts of Bulbus Allii macrostemonis, 6 parts of Radix Bupleuri, 6 parts of oyster shells, 9 parts of Rhizoma Chuanxiong, 5 parts of calamus rhizomes, 8 parts of dried leeches, 7 parts of Radix Astragali, 9 parts of Radix Codonopsis, 6 parts of kudzu vine roots, 15 parts of the bark of Ardisia densilepidotula, 7 parts of Solms-laubachia lanata, 6 parts of common alstonia leaves, 6 parts of whole hirsute gonostegia herb with roots, 11 parts of Chinese ilex leaves, 8 parts of licorice roots, 7 parts of the herb of little platanthera, 14 parts of weeping willow branches,10 parts of the seed of fistular onion, 8 parts of dried mature pulp of Cornus officinalis, 9 parts of the rhizome of Angiopteris hokouensis Ching and 10 parts of the rhizome-bark of common ginger. Clinical experiments prove that through reasonable combination of the traditional Chinese medicinal materials, the prepared Chinese herbal decoction is beneficial for treatment of Qi-Yin deficiency typeangina pectoris of coronary heart disease, can effectively reduce recurrence of Qi-Yin deficiency type angina pectoris of coronary heart disease and achieves good integral adjusting and long-term treatment effects.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction, in particular to a traditional Chinese medicine decoction for treating angina pectoris of coronary heart disease of Qi and Yin deficiency type. Background technique [0002] Coronary heart disease and angina pectoris are one of the most frequent and serious heart diseases in recent years, and the prevalence rate in the Chinese population is continuously increasing. At present, Western medicine treatment drugs are mainly nitrates, combined with lipid-lowering, anti-platelet, thrombolytic and anticoagulant drugs, so as to dilate coronary arteries. There are many kinds of drugs, and the damage to liver and kidney functions is self-evident. The cooperative application of surgery is only a simple symptomatic treatment, and it has not done a radical and effective treatment for the basic pathological changes of the disease. Due to the various etiologies of coronary heart disease and angina p...

AI Technical Summary

Problems solved by technology

In view of the complex interaction of various active ingredients of various Chinese medicinal materials in the body, changes in the pharmacokinetics and pharmacodynamics of various drugs in the body will have various effects on the interaction between drugs. When used in combination, it may not only produce synergistic drug effects, but also may produce antagonistic effects, which will lead to weakening of drug therapeutic effect or treatment failure. Some drugs in combination will also increase drug toxicity and cause adverse reactions; Enhanced, but when the therapeutic effect is excessively enhanced, it will exceed the body's ability to tolerate it, and it can also cause adverse reactions and even endanger patients.

Part of the research is to prepare traditional Chinese medicine prescriptions in order to treat angina pectoris of Qi and Yin deficiency type. The most common problem is that the compatibility of prescriptions is unreasonable. The scientific indicators are used to apply the theory of traditional Chinese medicine mechanically, and the flavors of the prescriptions are added or subtracted at will, resulting in unreasonable prescriptions and contradicting the theory of traditional Chinese medicine